A previous study of 4 patients defined Andersen's syndrome (AS) as a triad of potassium-sensitive periodic paralysis, ventricular dysrhythmias, and dysmorphic features. AS appears to be distinct in terms of its genetic defect from the a-subunit of skeletal muscle sodium channel and the cardiac potassium channel responsible for most long QT syndromes (LQT1). We studied 11 additional patients with AS from 5 kindreds. Spontaneous attacks of paralysis were associated with hypokalemia, normokalemia, or hyperkalemia. All 11 patients had similar dysmorphic features. The QT interval was prolonged in all patients although only 4 were symptomatic. Genetic linkage studies excluded linkage to the a-subunit of the skeletal muscle sodium channel and to four distinct LQT loci. In addition, none of the common dihydropyridine receptor mutations responsible for hypokalemic periodic paralysis were present. We conclude that (1) AS is a genetically unique channelopathy affecting both cardiac and skeletal membrane excitability, (2) attacks of paralysis may be either hypokalemic or hyperkalemic, (3) a prolonged QT interval is an integral feature of this syndrome, and (4) a prolonged QT interval may be the only sign in an individual from an otherwise typical AS kindred. This may be confused with more common, potentially lethal LQT syndromes.
I n three previously reported kindreds, periodic paralpsis was associated with hyperkalemia, but genetic linkage to the skeletal muscle sodium channel was excluded . Because QT, intervals were prolonged i n three of four of the reported cases, we screened for and excluded linkage to the long QT syndrome locus on chromosome 11 (LQT1) [17, 
Patients and Methods
We studied 11 patients from 5 kindreds by ncurological examination and electrocardiography (ECG). The index cases had the following: (1) an electromyography (EMG), to assess rnyotonia according to previously described protocols, including the exercise test [20] ; (2) a muscle biopsy; (3) hypokalemic and hyperkalemic challenges according to standard protocols [ 2 ] ; and (4) Stubbs [7] (1976; autosonial dominant)
Kramer et a1 [8] (1979); autosomal dominant) Yoshimura et a1 [9] (1 983; sporadic) Muscle biopsy was consistent with a mild chronic myopathy with tubular aggregates.
PATIENT 2 (FAMILY 1, 111-2). The 8-year-old sister of Patient l never experienced episodic weakness, although she had occasional bouts of palpitation. Examination showed a slender girl of short stature ((3rd percentile), mandibular hypoplasia, low-set ears, hypertelorism, clinodactyly of the fifth fingers of both hands, syndactyly of the second and third toes of her left foot (Fig D-F) . Findings of neurologic examination were normal. ECG showed a long QT interval (QT, = 0.48 msec). PATIENT 4 (FAMILY 1, 1-2). An 87-year-old woman, the paternal grandmother of Patients l and 2, had no episodes of weakness. Examination revealed features similar to those in other affected family members, ie, low-set ears, mandibular hypoplasia, clinodactyly of the fifth fingers of both hands, and syndactyly between the second and third fingers of both feet. Neuromuscular examination was normal. ECG showed asymptomatic bidirectional ventricular tachycardia and a prolonged QT interval (QT, = 0.48 msec).
PATIENT 5. A 16-year-old boy was referred for evaluation of episodic weakness. At age 7, a routine ECG showed asymptomatic ventricular tachycardia. H e was treated with amiodarone, which was discontinued 10 months later when he developed profound symptomatic bradycardia and other amiodarone side effects. A pacemaker was inserted and he was given flecainide. He had no cardiac symptoms thereafter. At age 14, he had episodes of transient weakness about once every 5 weeks. During one attack, the serum potassium level was 2.7 mEqlL. The family history was negative for any cardiac or neurologic disorder. O n examination, his height was normal for age. The following nondisfiguring distinctive features were evident: low-set ears, hypertelorism, micrognathia, bilaterally short index fingers that only come to the distal interphalangeal joint of his middle finger, mild clinodactyly of his fifth fingers, and hypoplastic and low-set thumbs with very smooth and flat palmar creases ( Fig. G-I her QT interval further. Now, almost a year off quinidine, the patient has no further cardiac symptoms. Her physical examination revealed a slender woman with high-arched palate, hypertelorism, bilateral ptosis, micrognathia, broad forehead, as well as hyperlordosis and scoliosis (Fig A-C) . Neurologic examination showed shoulder girdle atrophy with bilateral scapular winging associated with a 4-MRC grade proximal weakness in a "hip-girdle"-type distribution. Foot dorsiflexion was in the 4-range. Tendon reflexes were absent. She experiences occasional palpitations and has had one near syncopal episode in the last 3 years. A recent Holter monitor revealed frequent premature ventricular contractions, occasionally in groups, although she had no symptoms during the study. She continues to have two or three episodes of weakness per month. The patient was adopted, so a clear family history could not be obtained. However, she was told that her mother had similar distinctive features and a maternal grandmother died of cardiac arrest at age 45.
Genetic Analysis
ANDERSEN'S PEDIGREES. Three families were available to test the hypothesis that AS might be allelic with LQT syndrome. The kindreds were of insufficient size to demonstrate linkage with significant lod scores. However, given informative haplotypes, absence of linkage to a given locus can be demonstrated.
DNA ISOLATION AND MARKER ANALYSIS. High-molecular-weight genomic DNA was isolated from whole blood lisate with a phenollchloroform extraction followed by isopropanol precipitation. Genetic evaluation was undertaken in kindreds 1784, 3387, and 3442, using markers that are tightly linked to LQT loci. The markers genotyped in these families are shown in Table 2 . End-labeled primers were prepared as follows: 25 pinol of primer, 50 mM Tris-HC1, 10 mM MgCI,, 5.0 dithiothreitol, 8.4 U of T, polynucleotide kinase, and 6.0 ~1 of [y-32P]ATI' (5 mol/ml, in a total volume of 10 pl). This mixture was incubated at 37°C for 1 hour and was then heated to 94°C for 3 minutes to inactivate the T 4 polynucleotide kinase.
The polymerase chain reaction (PCR) was used to amplify total genomic DNA, using primers flanking polymorphic regions. The reaction mixture contained 50 ng of genomic DNA, 10 pmol of each primer, 1 pmol of the end-labeled primer, 2.5 nmol of each deoxynucleoside rriphosphate, 10 mM Tris-HCI (pH 8.4), 50 mM KCI, 1.5 MgC1, 1.0 Taq DNA polymerase (Promega) in a volume of 25 PI. I'CR was performed under the following conditions: (1) one cycle at 94°C for 3 minutes, (2) 30 cycles, each at 72°C for 45 seconds, and (3) cooling to 4°C. After PCR, 10 ~1 of stop dye (98% formamide, 0.05% bromphenol blue, 0.05% xylene cyanol, and 20 mM EDTA) was added. Four microliters of each sample was then loaded on a 6Yo acrylaniide gel that contained 5.6 M urea, 32% formamide, 90 mM Tris-borate, p H 7.5, and 2 mM EDTA. Preelectrophoresis of gels was at a constant power (80 W/gel) with 90 mM Tris-borate (pH 7.5) and 2 mM EDTA running buffer. Gels were placed on filter paper and exposed to x-ray film overnight at -20°C. Autoradiograms were analyzed for genotypes of the polymorphic alleles. The results of the DNA analysis on the recombinants to LQT loci are summarized in Table 2 .
Discussion
I n our initial study of AS, we defined a clinical triad to distinguish AS from other forms of periodic paralysis.
T h e present study confirmed the validity o f the triad, emphasizing intrafamilial phenotypic variability and establishing LQT as the most consistent cardiac maiiifehtation. However, contrary to our initial report, the associated periodic paralysis can be hyper-, hypo-, or normokalemic [23] .
In our initial report, 3 of 4 patients were normokalemic and I of 4 was hyperkalemic during spontaneous attacks. In all, attacks were induced by oral potassium challenge. They were therefore described as having potassium-sensitive periodic paralysis, implying a In retrospect, evaluation of changes in serum potassium in AS should be done only during spontaneous attacks of weakness. Provocative challenges, especially hypokalemic challenges, should not be undertaken in AS patients because hypokalemia may exacebate preexisting QT prolongation and potentially cause lifethreatening ventricular arrhythmias.
The constancy and distinctness of the physical fea- Because cardiac and skeletal muscle contain different isoforms of the major ion channel proteins, the coexistence of abnormalities of cardiac and skeletal muscle membrane excitability in AS suggests that the pathogenic mechanism must alter the function of more than one specific channel. This could be achieved by a defective regulatory protein common to both tissues [29] . "Patients from our previous report [13] .
Spoilt [K '1 = serum potassium levels (in mEq/L) during a spontaneous attack of weakness; CK = creatine kinase; (+) = present; (-) = absent; N = normal; ND = not done; TA = tubular aggregates; BVT = bidirectional ventricular tachycardia; AD = autosomal dominant; S = sporadic. Genetic heterogeneity in periodic paralysis with cardiac arrhythmia is likely. Before our 1994 report, other patients with periodic paralysis and cardiac arrhythmias had been described (see Table I ) [I, [4] [5] [6] [7] [8] [9] [10] [11] [12] . Only 2
were noted to have distinctive physical features [4, 101 and none had a prolonged QT, although it is unclear whether these features were specifically looked for. However, with the recent description of a case of periodic paralysis with cardiac arrhythmias associated with a sodium channel mutation [12] , it appears possible that there exist syndromes of periodic paralysis with cardiac involvement distinct from AS, although the gene defect has still to be identified. 
